[Skip to Navigation]
Sign In
Figure 1. Flowsheet of patients in the study. AK indicates actinic keratosis; SK, seborrheic keratosis; and SL, solar lentigo.

Figure 1. Flowsheet of patients in the study. AK indicates actinic keratosis; SK, seborrheic keratosis; and SL, solar lentigo.

Figure 2. Dermoscopic signs of actinic keratosis. A, Follicular openings with keratotic plugs (arrows). B, Erythematous pseudonetwork. C, Surface scale. D, Linear-wavy vessels surrounding hair follicles (arrows).

Figure 2. Dermoscopic signs of actinic keratosis. A, Follicular openings with keratotic plugs (arrows). B, Erythematous pseudonetwork. C, Surface scale. D, Linear-wavy vessels surrounding hair follicles (arrows).

Table 1. Comparison of Dermoscopic and Histopathological Diagnoses of Actinic Keratosis (AK) Among 178 Lesionsa
Table 1. Comparison of Dermoscopic and Histopathological Diagnoses of Actinic Keratosis (AK) Among 178 Lesionsa
Table 2. Sensitivity, Specificity, κ Index, and Positive and Negative Likelihood Ratios Among 4 Dermoscopic Signs of Actinic Keratosis
Table 2. Sensitivity, Specificity, κ Index, and Positive and Negative Likelihood Ratios Among 4 Dermoscopic Signs of Actinic Keratosis
Table 3. Results of the Pearson Product Moment χ2 Test to Determine Correlations Among 4 Dermoscopic Signs of Actinic Keratosis
Table 3. Results of the Pearson Product Moment χ2 Test to Determine Correlations Among 4 Dermoscopic Signs of Actinic Keratosis
1.
Feldman SR, Fleischer AB Jr, McConnell RC. Most common dermatologic problems identified by internists, 1990-1994.  Arch Intern Med. 1998;158(7):726-7309554678PubMedGoogle ScholarCrossref
2.
Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma.  Lancet. 1988;1(8589):795-7972895318PubMedGoogle ScholarCrossref
3.
Lebwohl M. Actinic keratosis: epidemiology and progression to squamous cell carcinoma.  Br J Dermatol. 2003;149:(suppl 66)  31-3314616345PubMedGoogle ScholarCrossref
4.
Jemal A, Tiwari RC, Murray T,  et al; American Cancer Society.  Cancer statistics, 2004.  CA Cancer J Clin. 2004;54(1):8-2914974761PubMedGoogle ScholarCrossref
5.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007.  CA Cancer J Clin. 2007;57(1):43-6617237035PubMedGoogle ScholarCrossref
6.
Suchniak JM, Baer S, Goldberg LH. High rate of malignant transformation in hyperkeratotic actinic keratoses.  J Am Acad Dermatol. 1997;37(3, pt 1):392-3949308551PubMedGoogle ScholarCrossref
7.
Zalaudek I, Ferrara G, Leinweber B, Mercogliano A, D’Ambrosio A, Argenziano G. Pitfalls in the clinical and dermoscopic diagnosis of pigmented actinic keratosis.  J Am Acad Dermatol. 2005;53(6):1071-107416310072PubMedGoogle ScholarCrossref
8.
Zalaudek I, Giacomel J, Argenziano G,  et al.  Dermoscopy of facial nonpigmented actinic keratosis.  Br J Dermatol. 2006;155(5):951-95617034524PubMedGoogle ScholarCrossref
9.
Peris K, Micantonio T, Piccolo D, Fargnoli MC. Dermoscopic features of actinic keratosis.  J Dtsch Dermatol Ges. 2007;5(11):970-97617908179PubMedGoogle ScholarCrossref
10.
Jaeschke R, Guyatt G, Sackett DL.Evidence-Based Medicine Working Group.  Users' guides to the medical literature, III: how to use an article about a diagnostic test, A: are the results of the study valid?  JAMA. 1994;271(5):389-3918283589PubMedGoogle ScholarCrossref
11.
Zalaudek I, Argenziano G, Leinweber B,  et al.  Dermoscopy of Bowen's disease.  Br J Dermatol. 2004;150(6):1112-111615214896PubMedGoogle ScholarCrossref
12.
Kreusch JF. Vascular patterns in skin tumors.  Clin Dermatol. 2002;20(3):248-25412074860PubMedGoogle ScholarCrossref
13.
Freedberg IM, ed, Eisen AZ, ed, Wolff K, ed,  et al.  Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill Press; 1999
14.
Marks R. Nonmelanotic skin cancer and solar keratoses. The quiet 20th century epidemic.  Int J Dermatol. 1987;26(4):201-2053298089PubMedGoogle ScholarCrossref
15.
Frost CA, Green AC. Epidemiology of solar keratoses.  Br J Dermatol. 1994;131(4):455-4647947197PubMedGoogle ScholarCrossref
16.
Venna SS, Lee D, Stadecker MJ, Rogers GS. Clinical recognition of actinic keratoses in a high-risk population: how good are we?  Arch Dermatol. 2005;141(4):507-50915837871PubMedGoogle ScholarCrossref
17.
Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use.  N Engl J Med. 1993;329(16):1147-11518377777PubMedGoogle ScholarCrossref
18.
Whited JD, Horner RD, Hall RP, Simel DL. The influence of history on interobserver agreement for diagnosing actinic keratoses and malignant skin lesions.  J Am Acad Dermatol. 1995;33(4):603-6077673492PubMedGoogle ScholarCrossref
19.
Horn M, Gerger A, Ahlgrimm-Siess V,  et al.  Discrimination of actinic keratoses from normal skin with reflectance mode confocal microscopy.  Dermatol Surg. 2008;34(5):620-62518429925PubMedGoogle ScholarCrossref
20.
Gerger A, Koller S, Weger W,  et al.  Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors.  Cancer. 2006;107(1):193-20016615102PubMedGoogle ScholarCrossref
21.
Ulrich M, Maltusch A, Rius-Diaz F,  et al.  Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses.  Dermatol Surg. 2008;34(5):610-61918261097PubMedGoogle ScholarCrossref
22.
Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma.  J Am Acad Dermatol. 2000;42(1, pt 2):4-710607349PubMedGoogle ScholarCrossref
23.
Zalaudek I, Giacomel J, Schmid K,  et al.  Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.  J Am Acad Dermatol. 2012;66(4):589-59721839538PubMedGoogle ScholarCrossref
Study
Oct 2012

Validation of Dermoscopy as a Real-time Noninvasive Diagnostic Imaging Technique for Actinic Keratosis

Author Affiliations

Author Affiliations: Department of Dermatology, Fuenlabrada University Hospital, Fuenlabrada (Drs Huerta-Brogeras, Borbujo, Hernández-Núñez, Castaño, Romero-Maté, Martínez-Sánchez, and Martínez-Morán), and Jazmín Health Center (Dr Olmos), Madrid, Spain.

Arch Dermatol. 2012;148(10):1159-1164. doi:10.1001/archdermatol.2012.1060
Abstract

Objective To validate dermoscopy as a real-time noninvasive diagnostic imaging technique for actinic keratosis (AK).

Design Prospective study to validate a diagnostic test.

Setting Dermatology department of a tertiary university hospital in Fuenlabrada, Madrid, Spain.

Patients A total of 178 patients with a clinical diagnosis of AK participated in the study.

Main Outcome Measures An independent blinded comparison was performed between dermoscopy results and histopathological findings, the gold standard for the diagnosis of AK. All the patients underwent both diagnostic tests.

Results One hundred seventy-eight lesions were evaluated. The concordance between dermoscopy results and histopathological findings was 0.917. The sensitivity of dermoscopy for the diagnosis of AK was 98.7%, with a specificity of 95.0%, a positive likelihood ratio of 19.74, and a negative likelihood ratio of 0.01. A diagnostic algorithm that combined follicular openings and erythematous pseudonetwork demonstrated a sensitivity of 95.6% and a specificity of 95.0% for the diagnosis of AK.

Conclusions The sensitivity and specificity of dermoscopy for the diagnosis of AK were high, as was the concordance between dermoscopy results and histopathological findings. As a real-time noninvasive diagnostic imaging technique for AK, dermoscopy may be incorporated in the management of patients with these lesions.

Actinic keratosis (AK) is defined as an in situ intraepidermal carcinoma or precancerous disease that occurs in areas of skin exposed to sunlight, characterized by the presence of an abnormal proliferation and differentiation of epidermal keratinocytes, with a risk for progression to infiltrating squamous cell carcinoma (SCC). In the United States, AK represents the third most frequent condition for which dermatologic consultation is sought, accounting for 11.2% of visits.1 The risk for transformation to SCC is 0.075% to 0.096% per AK lesion per year.2 This risk is cumulative in patients with multiple AK lesions and can reach 10% within 10 years or up to 20% among immunocompromised patients or those who remain untreated.3 Squamous cell carcinoma is a clinical, biological, and histopathological continuum of AK and is the principal cause of death from nonmelanoma skin cancer4-6; therefore, patients with AK are candidates for periodic follow-up dermatologic evaluation as outpatients.

Dermoscopy is a real-time noninvasive diagnostic imaging technique. For the user, its optical system renders the corneal layer translucent to improve vision, with original magnification ×10 to ×400. The technique increases the diagnostic accuracy of clinical evaluation by the dermatologist. The aim of dermoscopy is to overcome the imprecision and limits of clinical diagnosis that are associated with histopathological investigation, considered the gold standard technique by the scientific community. The dermoscopic signs of AK are erythematous pseudonetwork, surface scale, linear-wavy vessels, and follicular openings.7-9 The overall dermoscopic pattern of AK is a “strawberry” appearance. The primary objectives of the present study were to validate dermoscopy as a real-time noninvasive diagnostic imaging technique for AK (based on the presence of the strawberry pattern) and to measure the sensitivity, specificity, positive and negative likelihood ratios, and positive and negative predictive values compared with the gold standard of histopathological studies. Secondary objectives were the following: (1) to evaluate which of 4 dermoscopic signs was most sensitive and specific for AK, measuring the association between each dermoscopic sign and the histopathological diagnosis; (2) to describe new dermoscopic criteria (if detected) for the diagnosis of AK; (3) to assess the correlations or associations among the 4 dermoscopic signs that mimic the strawberry pattern of AK; (4) to determine the dermoscopic sign or combination of signs with the highest sensitivity and specificity for the diagnosis of AK; and (5) to study the relationship between the dermoscopic signs of AK and epidemiological data.

Methods

This prospective study was conducted in the Department of Dermatology, Fuenlabrada University Hospital, Madrid, Spain, during a 12-month period from June 1, 2006, through May 31, 2007. The study inclusion criterion was clinical suspicion of AK (ie, erythematous plaque with surface scale in an area of skin exposed to sunlight). Inclusion was not limited by the size of the lesions or by their clinical forms (ie, atrophic vs hypertrophic or pigmented vs nonpigmented). The study exclusion criteria were the following: pregnancy or breastfeeding, associated conditions that were contraindications to the use of local anesthesia to perform biopsy, and clinical suspicion of skin cancer melanoma or nonmelanoma (signs of infiltration, marked hyperkeratosis, or the presence of a hemorrhagic crust or bleeding). The ethics committee of Severo Ochoa Hospital, Madrid, Spain, evaluated and approved the research project. Informed consent was obtained from all study patients in accord with the principles of the Declaration of Helsinki. For a CI of 95% and a statistical power of 80%, calculation of the sample size for studies of diagnostic tests indicated that the estimated sample should comprise 172 analysis units (in this case, AK lesions). Only 1 lesion was studied in each patient. At the time of their inclusion in the study, all the patients underwent dermoscopy and histopathological investigation. Dermoscopic photographs were taken using a dermoscope (FOTO; DermLite) attached to a camera (400D; Canon). Histopathological investigation was performed on a punch biopsy specimen. An independent blinded comparison was performed between dermoscopy results and histopathological findings. To avoid bias because of revision of the diagnosis, an expert dermoscopist among us (M.H.B.) was blinded to the histopathological diagnosis; to avoid bias in the histopathological analysis, the pathologist who reviewed the specimen was blinded to the dermoscopic diagnosis.

In this series, dermoscopic diagnosis of AK was established by the presence of 2 or more of the following 4 dermoscopic signs: (1) erythematous pseudonetwork (pink erythematous base that is interrupted by the prominent follicular or adnexal openings), (2) surface scale (homogeneous areas or structures of yellow-white or brown), (3) linear-wavy vessels (fine, curved, wavy vessels around the white halo at the orifices of the hair follicles), and (4) follicular openings (yellow ovoid or globular structures with a white halo, forming a target image). Negative dermoscopic diagnosis of AK was based on the absence of at least 3 of 4 dermoscopic signs and the presence of criteria suggestive of other diagnoses, in particular the following vascular patterns: glomerular vessels in SCC, crown vessels in sebaceous hyperplasia, and arboriform telangiectasias in basal cell carcinoma. Dermoscopic images for each lesion were evaluated by the same observer (M.H.B.) at all the end points during the study period to confirm reproducibility of the results. In addition, the age, sex, skin phototype, and site of the lesion were recorded for each patient. In the histopathological study, the presence or absence of epidermal dysplasia was determined.

Statistical analysis was performed on data from lesions seen in the department that manifested clinical signs of AK. Sensitivity and specificity were determined for dermoscopic diagnosis and for each dermoscopic variable compared with routine histopathological studies as the reference, and P values were calculated using the χ2 tests. Nonparametric correlation (Pearson product moment χ2 test) was used to determine the association between individual dermoscopic variables. The concordance between dermoscopy results and histopathological findings was determined by calculating the κ value. All the data analyses were conducted using available software (SPSS for Windows version 12.0; SPSS Inc). For categorization purposes, classification and regression tree software (CART 4.0; Salford Systems) was used. In the latter analysis, classification trees were applied to learning sets to search for optimal split variables.

Results

In total, 178 lesions on 178 patients were clinically considered AK. All the patients agreed to participate in the study and signed the consent form. One hundred fifteen lesions (64.6%) were observed in men, and 63 lesions (35.4%) were observed in women. Patient age ranged from 37 to 97 years (mean age, 67 years). The most frequent sites of the lesions were the face (139 lesions [78.1%]) and the scalp (36 lesions [20.2%]); the remainder were on the back or the upper extremities.

Most patients (144 patients) had skin phototype II. The remaining patients had skin phototype III (28 patients) or skin phototype I (6 patients).

The dermoscopic diagnoses and histopathological diagnoses for 178 lesions are summarized in Table 1 and Figure 1. The histopathological types of AK were not recorded because such determination was excluded from the pathologist's usual practice for biopsy specimens of these lesions. Furthermore, the pathologist was blinded to the dermoscopic diagnosis.

Using histopathological findings as the gold standard test result, the sensitivity of dermoscopy for the diagnosis of AK was 98.7%, and the specificity was 95.0%. The proportion of false-positive results was 5.0%, and the proportion of false-negative results was 1.3%. The positive predictive value was 99.4%, and the negative predictive value was 90.5%. The concordance between dermoscopic results and histopathological findings, calculated using the κ statistic, was 0.917. Dermoscopic diagnosis of AK had a positive likelihood ratio of 19.74 and a negative likelihood ratio of 0.01. The 4 dermoscopic signs of AK are listed in Table 2, along with their individual sensitivities, specificities, κ indexes, and positive and negative likelihood ratios. Classification trees were used for the descriptive analysis, seeking the combination of dermoscopic signs that best predicted the histopathological results. A diagnostic algorithm that combined follicular openings and erythematous pseudonetwork demonstrated a sensitivity of 95.6% and a specificity of 95.0% for the diagnosis of AK.

Analysis of the correlation among the 4 dermoscopic signs using the Pearson product moment χ2 test revealed significant associations (P < .05) for surface scale, linear-wavy vessels, and follicular openings (Table 3). Analysis of the correlations between the dermoscopic signs and epidemiological data revealed the following 2 statistically significant findings (P < .05): linear-wavy vessels were more common in men, and follicular openings were less common in patients younger than 50 years (about 40% vs a mean of almost 80% in other age groups). In this series, 4 of 7 SCCs diagnosed based on histopathological findings had a vascular pattern suggestive of SCC on dermoscopy, while the only dermoscopic sign observed in 2 of these cases was hyperkeratotic surface scale.

Comment

The present study validated dermoscopy used on lesions selected by visual inspection as a real-time noninvasive diagnostic imaging technique for AK by comparing dermoscopy results with histopathological findings, achieving a sensitivity of 98.7% and a specificity of 95.0%. The concordance (κ index) between dermoscopy results and histopathological findings was 0.917. Based on considerations by the Evidence-Based Medicine Working Group,10 the positive and negative likelihood ratios (19.74 and 0.01, respectively, in this series) are clinically relevant to the interpretation of results because they respectively reflect increased and decreased likelihood that a diagnosis may or may not be accurate in a significant manner with respect to not performing a diagnostic test.

The aim of this study was to validate dermoscopic criteria for AK. The features most consistently found on dermoscopy were follicular openings and erythematous pseudonetwork. Follicular openings (Figure 2A) showed the highest concordance with the histopathological diagnosis (κ index, 0.556). This dermoscopic sign had more balanced values of sensitivity and specificity. Erythematous pseudonetwork (Figure 2B) was the most specific of 4 dermoscopic signs evaluated. On dermoscopy, the normal superficial vascular plexus is seen as a regular blurred network of wide vessels. When AK forms, edema and elastosis develop, producing a dermoscopic pattern of erythematous pseudonetwork. One of the characteristics of aging skin is a loss of the vascular bed, and most AK lesions are observed in older individuals. The vessels in AK may be present in the most atrophic areas of the epidermis and dermis, around the orifices of the adnexa and follicles. The combination of dermoscopic signs was sought that provided the highest diagnostic accuracy using classification trees. According to this descriptive method, the results herein demonstrate that the diagnosis of AK could be based on the combination of follicular openings and erythematous pseudonetwork, with a sensitivity of 95.6%, a specificity of 95.0%, and a κ index of 0.801). The diagnostic accuracy of this combination could be considered equivalent to that of the strawberry pattern observed by Zalaudek et al.8 Surface scale (Figure 2C) was the most sensitive dermoscopic sign but had the lowest specificity and the lowest positive predictive value. This dermoscopic sign has been reported in other neoplastic diseases such as Bowen disease11 and lichenoid keratosis, as well as in certain inflammatory skin lesions such as psoriasis. Linear-wavy vessels (Figure 2D) represent a highly specific (95.0%) but not particularly sensitive (65.8%) dermoscopic sign.

The dermoscopic vascular pattern is considered more relevant in nonpigmented skin lesions12 such as AK. Proof of this in the present study is the high positive predictive value (99.0%) for the presence of these characteristic vessels. Assessment of the possible relationships across dermoscopic criteria showed that the vascular pattern was associated with surface scale and with follicular openings. The presence of erythematous pseudonetwork showed a statistically significant correlation with the presence of follicular openings. This association is logical given the origin of erythematous pseudonetwork, described in the previous paragraph. An evaluation was also performed of the relationship between the dermoscopic signs of AK and epidemiological data. Statistically significant associations were found with 2 dermoscopic signs: linear-wavy vessels were more common in men, and follicular openings were less common in patients younger than 50 years. The dermis underlying an AK lesion manifests actinic elastosis and vascular ectasia, correlating with the vascular structures visualized on dermoscopy. In this series, actinic elastosis was significantly more common in men than in women, a finding that may be explained by greater occupational exposure to sunlight among men. The fact that follicular openings were more common in older patients may be explained by the aging of the skin, which leads to approximately a 23% reduction13 in sebum production per decade, with greater cutaneous xerosis and more compaction of the stratum corneum.

Dermoscopy may be a promising technique for noninvasive detection of AK, perhaps overcoming the imprecision and limits of clinical diagnosis that are associated with histopathological investigation. Among various studies,14-18 the positive predictive value for clinical diagnosis has ranged between 74% and 81%. In this study, clinical diagnosis and dermoscopic diagnosis achieved positive predictive values of 88.7% and 99.4%, respectively. Notably, these values are higher than those reported for reflectance confocal microscopy, which is a noninvasive diagnostic tool with results closely linked to histopathological findings.19-21 Actinic keratosis may be considered a precursor of SCC.22 The authors of a retrospective study23 proposed a progressive dermoscopic model in which AK develops into intraepidermal carcinoma and invasive SCC. The present study extends their results by providing the sensitivity and specificity for 2 of their evaluated criteria, namely, erythematous pseudonetwork and follicular openings. According to their findings, a red erythematous pseudonetwork was seldom seen in intraepidermal carcinoma or invasive SCC, and it was the most specific feature associated with AK. Those authors found that the presence of dotted or glomerular vessels and discrete yellow-white opaque scales was significantly associated with intraepidermal carcinoma, while the present study found surface scales to be the least specific among 4 dermoscopic signs of AK.

Limitations of the present study include that no anatomicoclinical classification of AK (eg, atrophic vs hypertrophic or pigmented vs nonpigmented) was performed. Correlations between the dermoscopic criteria and the histopathological and clinical types of AK could be a subject for future studies. As with most diagnostic techniques in the health sciences, correct dermoscopic technique requires training. The dermoscopy herein was performed by a dermatologist with considerable experience in dermoscopy. Future studies will be designed to determine interobserver variability in the technique.

The findings of the present study have major practical applications in the field of skin cancer. The use of dermoscopy is described for the diagnosis of AK; this noninvasive technique can be performed in the office as part of daily clinical practice and provides immediate results, with consequent prognostic and therapeutic implications. Because dermoscopy is not a costly technique, its use is important not only for the individual patient and physician but also for the health system in general. Dermoscopy may be incorporated as a noninvasive strategy for the diagnosis of AK and in the management of patients with these lesions.

Back to top
Article Information

Correspondence: María Huerta-Brogeras, MD, PhD, Department of Dermatology, Fuenlabrada University Hospital, 2 Camino del Molino, 28942 Fuenlabrada, Madrid, Spain (mhuerta.hflr@salud.madrid.org).

Accepted for Publication: March 10, 2012.

Author Contributions: Drs Huerta-Brogeras, Olmos, Borbujo, Hernández-Núñez, Castaño, Romero-Maté, Martínez-Sánchez, and Martínez-Morán had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Huerta-Brogeras, Olmos, and Borbujo. Acquisition of data: Huerta-Brogeras, Hernández-Núñez, Castaño, Romero-Maté, Martínez-Sánchez, and Martínez-Morán. Analysis and interpretation of data: Huerta-Brogeras, Borbujo, and Martínez-Sánchez. Drafting of the manuscript: Huerta-Brogeras, Castaño, Romero-Maté, Martínez-Sánchez, and Martínez-Morán. Critical revision of the manuscript for important intellectual content: Huerta-Brogeras, Olmos, Borbujo, Hernández-Núñez, Castaño, and Romero-Maté. Statistical analysis: Huerta-Brogeras, Olmos, and Borbujo. Obtained funding: Huerta-Brogeras. Administrative, technical, and material support: Huerta-Brogeras and Martínez-Morán. Study supervision: Huerta-Brogeras, Olmos, Borbujo, Hernández-Núñez, Castaño, and Romero-Maté.

Financial Disclosure: None reported.

Funding/Support: This study was supported in part by a grant PI 07/00735 from the Carlos III Health Institute Research Fund for Research in Health Technology and by grant BE67392009 from the Mutua Madrileña Foundation for Medical Research. These grants were from public funds.

Role of the Sponsor: The sponsors had no role in the design or conduct of the study; in the collection, analysis,or interpretation of the data; or in the preparation, review, or approval of the manuscript.

Additional Contributions: Jesús Juan Ruiz, PhD, provided advice on the statistical analysis.

References
1.
Feldman SR, Fleischer AB Jr, McConnell RC. Most common dermatologic problems identified by internists, 1990-1994.  Arch Intern Med. 1998;158(7):726-7309554678PubMedGoogle ScholarCrossref
2.
Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma.  Lancet. 1988;1(8589):795-7972895318PubMedGoogle ScholarCrossref
3.
Lebwohl M. Actinic keratosis: epidemiology and progression to squamous cell carcinoma.  Br J Dermatol. 2003;149:(suppl 66)  31-3314616345PubMedGoogle ScholarCrossref
4.
Jemal A, Tiwari RC, Murray T,  et al; American Cancer Society.  Cancer statistics, 2004.  CA Cancer J Clin. 2004;54(1):8-2914974761PubMedGoogle ScholarCrossref
5.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007.  CA Cancer J Clin. 2007;57(1):43-6617237035PubMedGoogle ScholarCrossref
6.
Suchniak JM, Baer S, Goldberg LH. High rate of malignant transformation in hyperkeratotic actinic keratoses.  J Am Acad Dermatol. 1997;37(3, pt 1):392-3949308551PubMedGoogle ScholarCrossref
7.
Zalaudek I, Ferrara G, Leinweber B, Mercogliano A, D’Ambrosio A, Argenziano G. Pitfalls in the clinical and dermoscopic diagnosis of pigmented actinic keratosis.  J Am Acad Dermatol. 2005;53(6):1071-107416310072PubMedGoogle ScholarCrossref
8.
Zalaudek I, Giacomel J, Argenziano G,  et al.  Dermoscopy of facial nonpigmented actinic keratosis.  Br J Dermatol. 2006;155(5):951-95617034524PubMedGoogle ScholarCrossref
9.
Peris K, Micantonio T, Piccolo D, Fargnoli MC. Dermoscopic features of actinic keratosis.  J Dtsch Dermatol Ges. 2007;5(11):970-97617908179PubMedGoogle ScholarCrossref
10.
Jaeschke R, Guyatt G, Sackett DL.Evidence-Based Medicine Working Group.  Users' guides to the medical literature, III: how to use an article about a diagnostic test, A: are the results of the study valid?  JAMA. 1994;271(5):389-3918283589PubMedGoogle ScholarCrossref
11.
Zalaudek I, Argenziano G, Leinweber B,  et al.  Dermoscopy of Bowen's disease.  Br J Dermatol. 2004;150(6):1112-111615214896PubMedGoogle ScholarCrossref
12.
Kreusch JF. Vascular patterns in skin tumors.  Clin Dermatol. 2002;20(3):248-25412074860PubMedGoogle ScholarCrossref
13.
Freedberg IM, ed, Eisen AZ, ed, Wolff K, ed,  et al.  Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill Press; 1999
14.
Marks R. Nonmelanotic skin cancer and solar keratoses. The quiet 20th century epidemic.  Int J Dermatol. 1987;26(4):201-2053298089PubMedGoogle ScholarCrossref
15.
Frost CA, Green AC. Epidemiology of solar keratoses.  Br J Dermatol. 1994;131(4):455-4647947197PubMedGoogle ScholarCrossref
16.
Venna SS, Lee D, Stadecker MJ, Rogers GS. Clinical recognition of actinic keratoses in a high-risk population: how good are we?  Arch Dermatol. 2005;141(4):507-50915837871PubMedGoogle ScholarCrossref
17.
Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use.  N Engl J Med. 1993;329(16):1147-11518377777PubMedGoogle ScholarCrossref
18.
Whited JD, Horner RD, Hall RP, Simel DL. The influence of history on interobserver agreement for diagnosing actinic keratoses and malignant skin lesions.  J Am Acad Dermatol. 1995;33(4):603-6077673492PubMedGoogle ScholarCrossref
19.
Horn M, Gerger A, Ahlgrimm-Siess V,  et al.  Discrimination of actinic keratoses from normal skin with reflectance mode confocal microscopy.  Dermatol Surg. 2008;34(5):620-62518429925PubMedGoogle ScholarCrossref
20.
Gerger A, Koller S, Weger W,  et al.  Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors.  Cancer. 2006;107(1):193-20016615102PubMedGoogle ScholarCrossref
21.
Ulrich M, Maltusch A, Rius-Diaz F,  et al.  Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses.  Dermatol Surg. 2008;34(5):610-61918261097PubMedGoogle ScholarCrossref
22.
Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma.  J Am Acad Dermatol. 2000;42(1, pt 2):4-710607349PubMedGoogle ScholarCrossref
23.
Zalaudek I, Giacomel J, Schmid K,  et al.  Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.  J Am Acad Dermatol. 2012;66(4):589-59721839538PubMedGoogle ScholarCrossref
×